AdvantCare®

One platform.
Eight capabilities.

AdvantCare®

AdvantCare® is Aenduo’s medical platform for the end-to-end management of patients remotely, supporting the care journey from prescription to follow up through treatment and diagnostics.

It addresses two key needs:

Older adults receiving care at home: improving treatment adherence, helping prevent cognitive decline, and reducing the risk of social isolation.
Patients with chronic conditions: enabling continuous, longitudinal monitoring across respiratory care, oncology, and chronic disease management.

AdvantCare® supports multiple clinical areas, including respiratory care, dialysis, nutrition, oncology, comorbidities, and frailty, combining treatment adherence monitoring with advanced patient monitoring based on biomedical parameters and Patient-Reported Outcomes (PROs). Its AI-powered predictive analytics identify adherence trends and emerging patient risks, supporting more proactive and personalized care.

Integrated Devices

AdvantCare® integrates more than 100 medical devices, including diagnostic devices such as ECGs, PSG systems, spirometers, and pulse oximeters; treatment devices such as ventilators and infusion pumps; and self-monitoring devices such as blood pressure monitors, scales, and glucometers. The platform also supports the integration of third-party devices.

Compliance, Security and Data Sovereignty

From a regulatory and security perspective, AdvantCare® is certified as Software as a Medical Device (SaMD) and CE-marked as a Class IIa medical device under Regulation (EU) 2017/745 (registration ID BD/RDM 2141267).

It is ACN QC1-qualified, operated in compliance with the NIS2 Directive, and GDPR compliant.

The platform provides full interoperability through the HL7 FHIR standard and ensures full data sovereignty: its technology is developed entirely in Italy.